GlassScriptPhysician profile
Kerry Ann Farrell
NPI 1891022448
$4,360.44
in general payments reported to CMS, 2019-2025
19 companies · $1,342 in 2025
The $1,342 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $286 · 2022: $22.64 · 2023: $562 · 2024: $2,148 · 2025: $1,342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,768 · Education: $285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,767.51 |
| Education | $284.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $898.51 | 2023-2025 | |
| Abbvie INC. | $605.86 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $586.79 | 2021-2025 | Dupixent, Libtayo |
| Sun Pharmaceutical Industries INC. | $452.97 | 2021-2025 | Ilumya |
| E.R. Squibb & Sons, L.L.C. | $389.09 | 2023-2025 | Sotyktu |
| Lilly USA, LLC | $376.04 | 2024-2025 | Ebglyss, Olumiant, Taltz |
| Incyte Corporation | $338.72 | 2021-2025 | Opzelura |
| Arcutis Biotherapeutics, INC. | $152.23 | 2023-2025 | Zoryve |
| Janssen Biotech, INC. | $107.93 | 2024-2025 | Tremfya |
| Ucb, INC. | $73.08 | 2024-2025 | Bimzelx |
| Sanofi-Aventis U.S. LLC | $71.28 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $66.49 | 2024-2025 | Cabtreo, Jublia, Arazlo |
| Amgen INC. | $52.55 | 2024 | Otezla |
| Galderma Laboratories, L.P. | $52.00 | 2025 | Nemluvio |
| Novartis Pharmaceuticals Corporation | $41.18 | 2024-2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $38.71 | 2024 | |
| Allergan, INC. | $21.52 | 2021 | |
| Mimedx Group, INC. | $18.14 | 2025 | |
| Journey Medical Corporation | $17.35 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kerry Farrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.